Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets
Shahinda S. R. Alsayed, Hendra Gunosewoyo · International Journal of Molecular Sciences · 2023 · Review
Full textCC BY
Infectious Diseases
Filters3 filters applied
Year
Readable here
Study type
Licence
Clinical Impact of Staphylococcus aureus Skin and Soft Tissue Infections
Matthew S. Linz, Arun Mattappallil, Diana Finkel et al. · Antibiotics · 2023 · Review
Full textCC BY
The development of COVID-19 treatment
Yongliang Yuan, Baihai Jiao, Lili Qu et al. · Frontiers in Immunology · 2023 · Review
Full textCC BY
Antifungal Drug Resistance: An Emergent Health Threat
Antonio Vitiello, Francesco Ferrara, Mariarosaria Boccellino et al. · Biomedicines · 2023 · Review
Full textCC BY
Diagnosis of invasive fungal infections: challenges and recent developments
Wenjie Fang, Junqi Wu, Mingrong Cheng et al. · Journal of Biomedical Science · 2023 · Review
Full textCC BY
Pathogenicity and virulence of Mycobacterium tuberculosis
Kathryn C. Rahlwes, Beatriz R.S. Dias, Priscila C. Campos et al. · Virulence · 2023 · Review
Full textCC BY
Percentage of Asymptomatic Infections among SARS-CoV-2 Omicron Variant-Positive Individuals: A Systematic Review and Meta-Analysis
Weijing Shang, Liangyu Kang, Guiying Cao et al. · Vaccines · 2022 · Review
Full textCC BY
Echinocandins – structure, mechanism of action and use in antifungal therapy
Mateusz Szymański, Sandra Chmielewska, Urszula Czyżewska et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2022 · Review
Full textCC BY
SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines
Suresh Thakur, Shalitha Sasi, Sindhu Gopinathan Pillai et al. · Frontiers in Medicine · 2022 · Review
Full textCC BY
Evolution of the SARS‐CoV‐2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission
Lok Bahadur Shrestha, Charles Foster, William Rawlinson et al. · Reviews in Medical Virology · 2022 · Review
Full textCC BY
Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages
Shuai Xia, Lijue Wang, Yun Zhu et al. · Signal Transduction and Targeted Therapy · 2022 · Review
Full textCC BY
A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies
Monika Kumari, Ruei-Min Lu, Mu-Chun Li et al. · Journal of Biomedical Science · 2022 · Review
Full textCC BY
When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis
Teny M. John, Ceena N. Jacob, Dimitrios P. Kontoyiannis · Journal of Fungi · 2021 · Review
Full textCC BY
SARS-CoV-2: from its discovery to genome structure, transcription, and replication
Ayslan Castro Brant, Wei Tian, Vladimir Majerciak et al. · Cell & Bioscience · 2021 · Review
Full textCC BY
Epidemiology of Mucormycosis in India
Hariprasath Prakash, Arunaloke Chakrabarti · Microorganisms · 2021 · Review
Full textCC BY
The Role of Th17 Response in COVID-19
Diana Martonik, Anna Parfieniuk-Kowerda, Magdalena Rogalska et al. · Cells · 2021 · Review
Full textCC BY
Persistence of Pathogens on Inanimate Surfaces: A Narrative Review
Jan Erik Wißmann, Lisa Kirchhoff, Yannick Brüggemann et al. · Microorganisms · 2021 · Review
Full textCC BY
SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns
Natalia Redondo, Sara Zaldívar-López, Juan J. Garrido et al. · Frontiers in Immunology · 2021 · Review
Full textCC BY
Obesity and COVID-19: what makes obese host so vulnerable?
Sameer Mohammad, Rafia Aziz, Saeed Al Mahri et al. · Immunity & Ageing · 2021 · Review
Abstract only
COVID-19 vaccines
Duduzile Ndwandwe, Charles S Wiysonge · Current Opinion in Immunology · 2021 · Review
Abstract only